Andrew Smolen is a research associate at IBG whose background is
in the fields of biochemistry and pharmacology. In addition to directing
the IBG Core Genotyping and Sequencing Laboratory, he is co-investigator
on several large-scale behavioral genetics projects including a
study of alcohol use and behavioral problems in subjects from the
National Youth Study and a study of DSM-IV criteria of ADHD diagnosis
and genetic correlates in an ethnically diverse community sample.
He is currently investigating associations of candidate dopaminergic
and serotinergic genes with substance abuse, personality traits
and problem behaviors; and the association of a possible susceptibility
locus defined by a QTL on chromosome 6p21.3 with ADHD in children
from three ethnic groups.